tiprankstipranks
Trending News
More News >
4SC AG (GB:0R6U)
LSE:0R6U
Advertisement

4SC AG (0R6U) Price & Analysis

Compare
0 Followers

0R6U Stock Chart & Stats


0R6U FAQ

What was 4SC AG’s price range in the past 12 months?
4SC AG lowest share price was €7.83 and its highest was €7.83 in the past 12 months.
    What is 4SC AG’s market cap?
    4SC AG’s market cap is €5.56M.
      When is 4SC AG’s upcoming earnings report date?
      4SC AG’s upcoming earnings report date is Oct 17, 2025 which is in 43 days.
        How were 4SC AG’s earnings last quarter?
        4SC AG released its earnings results on Aug 08, 2025. The company reported -€0.302 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.302.
          Is 4SC AG overvalued?
          According to Wall Street analysts 4SC AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does 4SC AG pay dividends?
            4SC AG does not currently pay dividends.
            What is 4SC AG’s EPS estimate?
            4SC AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does 4SC AG have?
            4SC AG has 10,906,089 shares outstanding.
              What happened to 4SC AG’s price movement after its last earnings report?
              4SC AG reported an EPS of -€0.302 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of 4SC AG?
                Currently, no hedge funds are holding shares in GB:0R6U

                4SC AG Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                0.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                -288.87%
                Trailing 12-Months
                Asset Growth
                7.49%
                Trailing 12-Months

                Company Description

                4SC AG

                4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. The company's pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat.

                4SC AG (0R6U) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Biotest
                B.R.A.I.N. Biotechnology Research and Information Network
                Heidelberg Pharma AG
                CytoTools AG
                Formycon AG
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis